Advancing the neuroelectrophysiological understanding of attentional switching dysfunction in major depressive disorder

Abstract

Attentional dysfunction, particularly impaired switching between tasks and emotional stimuli, is a core and persistent deficit in major depressive disorder (MDD) that contributes to functional disability and poor treatment outcomes. Event-related potentials (ERPs) provide a high-temporal-resolution for examining the neural dynamics underlying these impairments. This article synthesizes evidence on the neuroelectrophysiological correlates of attentional switching dysfunction in MDD, with emphasis on findings and methodological contributions from previous study. We examined studies investigating ERP components [e.g., N100, P200, P300, Late Positive Potential (LPP)] during attentional switching and emotional processing tasks. Converging evidence indicates that MDD is associated with reduced P200 and LPP amplitudes, reflecting deficits in early attentional engagement and sustained elaborative processing, particularly in response to negative emotional stimuli. These abnormalities are linked to poorer behavioral performance under high cognitive load and appear more pronounced in higher-order attentional control than in basic sensory processing. ERP biomarkers, especially P200 and LPP, provide objective indices of attentional dysfunction and may support improved assessment, targeted cognitive interventions, and treatment monitoring. Future research should prioritize longitudinal, multimodal, and large-scale designs to facilitate clinical translation.

Key Words: Major depressive disorder; Attentional switching; Event-related potentials; Dual-task paradigm; Cognitive dysfunction; Neurophysiological biomarkers; Emotional processing; Executive function; Late positive potential; P200

Core Tip: This article synthesizes neuroelectrophysiological evidence on attentional switching deficits in major depressive disorder (MDD). MDD patients exhibit reduced P200 and late positive potential amplitudes during tasks requiring attention shifts, especially towards negative emotional stimuli. These event-related potential abnormalities pinpoint dysfunctions in early attentional engagement and sustained emotional processing. The use of ecologically valid dual-task paradigms strengthens these findings. The identified event-related potential markers hold significant promise for refining the cognitive profile of MDD, guiding targeted interventions like attention bias modification, and monitoring treatment response, paving the way for a more neuroscience-informed approach to understanding and treating depression-related cognitive dysfunction.

INTRODUCTION

Major depressive disorder (MDD) is a prevalent and debilitating mental illness characterized not only by affective symptoms but also by significant cognitive impairments. Among these, deficits in executive functions, particularly attentional control and switching, are increasingly recognized as core features that contribute substantially to functional disability and perpetuate the disorder[1-3]. Attentional switching - the ability to flexibly shift the focus of attention between different tasks, rules, or stimuli - is fundamental for adaptive behavior in dynamic environments. In MDD, this ability is often compromised, particularly in the presence of negative emotional information, leading to a pervasive bias toward mood-congruent material and difficulty disengaging from negative thoughts[4-8].

The study by Wu et al[9] represents a substantial advancement in elucidating the neuroelectrophysiological underpinnings of this specific cognitive deficit. By employing an innovative dual-task paradigm that combines auditory discrimination with emotional facial recognition, and by analyzing multiple event-related potential (ERP) components across varying processing delays, their work provides a temporally precise account of how attentional switching is disrupted in MDD. Their findings of reduced P200 and late positive potential (LPP) amplitudes provide direct neural evidence of dysfunction at both early attentional engagement and later sustained processing stages.

Historically, research on cognitive aspects of depression has relied heavily on behavioral measures and functional neuroimaging. ERPs complement these approaches by offering millisecond-level temporal resolution, enabling the dissociation of rapid-stage cognitive processes that are not captured by behavioral outcomes or slower hemodynamic responses[10]. As cognitive dysfunction becomes an increasingly important target for intervention in MDD[11,12], identifying reliable, quantifiable, and mechanistically informative neurophysiological biomarkers is essential for developing objective diagnostics and personalized therapeutic strategies[13,14].

OBJECTIVES OF THIS REVIEW

This article aims to move beyond commentary on a single study and provide a comprehensive integrative review. Specifically, we will: (1) Contextualize the findings of Wu et al[9] within the broader theoretical and empirical literature on attention and emotion in MDD; (2) Critically analyze the methodological paradigms used to study attentional switching and their associated ERP correlates; (3) Synthesize evidence on specific ERP components (P200, LPP, P300) as potential biomarkers; (4) Discuss the clinical implications of these neuroelectrophysiological insights for assessment and treatment; and (5) Outline future research directions to bridge the gap between neuroscientific discovery and clinical application.

LITERATURE SEARCH AND METHOD

This article was conducted to synthesize contemporary evidence on the neuroelectrophysiology of attentional switching in MDD. Although it is not a systematic review with a pre-registered protocol, a structured search strategy was employed to ensure comprehensiveness. Primary focus was placed on the seminal study by Wu et al[9], which serves as the anchor for this synthesis. To contextualize and expand upon its findings, supplemental searches were conducted in PubMed and Google Scholar for relevant literature published between 2000 and 2024. Search terms included combinations of (“major depressive disorder” OR “depression”) AND (“attentional switching” OR “task switching” OR “attention bias” OR “cognitive control”) AND (“event-related potential” OR “ERP” OR “EEG”) AND (“emotion” OR “emotional face”). Priority was given to meta-analyses, randomized controlled trials, longitudinal studies, and studies employing innovative cognitive-emotional paradigms. Key theoretical and foundational studies (e.g., on cognitive models of depression, ERP methodology) were also included. Over 60 references were selected based on their relevance to core themes, including attentional biases, specific ERP components, methodological design, and clinical translation. Data and themes were synthesized narratively to provide a coherent critical overview of the field.

COMPARATIVE ANALYSIS OF ERP FINDINGS IN MDD

Theoretical framework and pathophysiological basis

The findings of Wu et al[9] are consistent with leading cognitive models of depression. Beck’s cognitive model[15] and its neuroscientific elaborations[16] posit that MDD is characterized by dysfunctional schemas that lead to preferential processing of negative information. This is operationalized as an attentional bias toward negative stimuli, which is well documented in behavioral and eye-tracking studies[5,17,18]. The reduced P200 amplitude for angry faces observed by Wu et al[9] may reflect disruption in early orienting toward or engagement with salient negative cues. Conversely, the blunted LPP suggests impairment in subsequent elaborative processing or maintenance of emotional information, potentially linked to emotional context insensitivity[19] or anhedonia. This pattern aligns with integrative models proposing both initial hyper-reactivity to threat and reduced sustained engagement with motivationally significant stimuli[20,21].

Furthermore, these ERP abnormalities can be interpreted through the lens of attentional control theory[22] and its application to depression. This theory suggests that depression impairs the efficiency of the goal-directed “central executive” attentional system, particularly under conditions of high cognitive load or emotional challenge. The dual-task paradigm used by Wu et al[9] explicitly creates such high-load conditions, and the observed deficit at short stimulus-onset asynchronies (SOAs) provides strong support for impaired executive control, particularly in the rapid reconfiguration of mental sets[23].

DIFFERENTIAL EFFECTS ACROSS EMOTIONAL STIMULI

Wu et al’s[9] observation of more pronounced deficits for angry faces provides important insights into the specificity of emotional processing biases in MDD. This finding aligns with the threat-related bias hypothesis, a core component of cognitive models[15,16]. Angry faces are potent social threat signals, and their disproportionate capture of attentional resources in MDD may reflect hyper-sensitivity of neural alarm systems, such as the amygdala[24,25]. ERP studies using visual search and dot-probe paradigms have consistently shown that depression is associated with difficulty disengaging attention from angry or sad faces[8,26], a process that is crucial for efficient attentional switching[27,28].

Conversely, the relative preservation of processing for happy faces is noteworthy. Some theories, such as the positive attenuation hypothesis or emotion context insensitivity[19], propose that MDD involves a general blunting of responses to emotional stimuli. However, the differential pattern (greater impairment for angry faces and relatively preserved processing for happy faces) observed by Wu et al[9] and others[29,30] supports a more nuanced negativity dominance model. This model suggests that the primary dysfunction lies in enhanced processing of negative stimuli, which consumes attentional resources and interferes with the processing of neutral or positive information, as well as with cognitive switching[4,31]. This interference effect is likely a key mechanism linking emotional bias to cognitive impairment (Table 1)[32-34].

Table 1 Summary of evidence for emotional interference in attentional switching in major depressive disorder.

Aspect of interference	Behavioral evidence	ERP/neurophysiological evidence	Theoretical interpretation
Engagement/attention capture by negative stimuli	Slower response times on trials following negative stimuli; difficulty ignoring negative distractors	Enhanced early components (P1, N170) and/or reduced P200 to negative vs neutral/positive stimuli	Hyper-vigilance or facilitated early orientation towards threat/mood-congruent information
Disengagement difficulty from negative stimuli	Increased response time cost when shifting attention away from a negative cue/location	Prolonged late positivity (LPP) or sustained frontal negativity for negative stimuli; reduced P300 for subsequent targets	Impaired top-down control to terminate processing of negative information, leading to “sticky” attention
Impaired switching in negative context	Poorer accuracy and slower switching specifically when negative material is involved	Reduced P300 and LPP amplitudes on switch trials with emotional vs. neutral stimuli; altered fronto-central theta synchronization	Negative emotion consumes/degrades executive resources needed for set-shifting and task reconfiguration
Blunted processing of positive stimuli	Reduced facilitation from positive cues; diminished reward learning	Attenuated LPP and RewP to positive/rewarding stimuli	Anhedonia and reduced motivational salience of positive information, failing to provide a protective or facilitative effect on switching

ERP: Event-related potential; LPP: Late positive potential; RewP: Reward positivity.

TEMPORAL DYNAMICS OF ATTENTIONAL SWITCHING

The manipulation of SOA in Wu et al’s paradigm[9] provides valuable insight into the temporal dynamics of attentional switching in patients with MDD. Patients exhibited greater impairments at the shortest SOA (500 milliseconds), indicating difficulty in rapidly shifting attention between concurrent tasks. This pattern suggests a specific deficit in the rapid reconfiguration of task sets, a process essential for adaptive behavior in dynamic environments[23].

The preservation of performance at longer SOAs implies that, given sufficient processing time, patients with MDD can achieve adequate task performance, potentially through alternative neural mechanisms. This temporal pattern has important implications for understanding the nature of cognitive deficits in MDD and highlights potential avenues for compensatory remediation strategies (Table 2).

Table 2 Key event-related potential components implicated in attentional and emotional processing dysfunction in major depressive disorder.

ERP component	Typical latency	Functional/cognitive significance	Typical finding in MDD	Postulated implication in attentional switching
P100/N170	80-170 ms	Early sensory processing/structural encoding of faces.	Often intact or even enhanced for emotional faces	Suggests basic perceptual encoding is not the primary deficit. May feed heightened signal to later stages
P200	150-250 ms	Early attentional engagement, initial stimulus evaluation, and categorization	Reduced amplitude, especially for negative emotional stimuli	Indicates impaired early filtering and resource allocation to task-relevant or emotional features during a switch
N200	200-350 ms	Conflict monitoring, response inhibition	Findings mixed; may be enhanced in contexts of high conflict	Could relate to increased conflict detection during switching, especially when inhibiting a pre-potent response
P300	300-500 ms	Context updating, attention allocation, and memory processing	Robustly reduced amplitude across many paradigms	Reflects broader deficits in updating mental representations and allocating resources after a task switch
LPP	400-1000 ms	Sustained attention, elaborative processing, and motivational significance of stimuli	Reduced amplitude, particularly for positive and sometimes negative stimuli	Indicates failure to maintain focused cognitive resources on task-relevant or emotional information over time
ERN	50-100 ms	Early, automatic error detection	Often enhanced amplitude	Suggests hyper-vigilant performance monitoring, which may be maladaptive and contribute to rumination

ERN: Error-related negativity; ms: Millisecond; ERP: Event-related potential; MDD: Major depressive disorder; LPP: Late positive potential.

METHODOLOGICAL ADVANCES AND RESEARCH TRENDS

Innovative paradigm design

Wu et al’s paradigm[9] exemplifies the shift toward more ecologically valid and complex assessments in cognitive neuroscience. Traditional single-task oddball or flanker paradigms, while valuable for isolating specific processes[10], lack the dynamic interplay of cognitive demands found in daily life. Dual-task and task-switching paradigms[23,35] introduce the critical element of interference and the need for active control, more closely reflecting real-world situations in which individuals must manage multiple streams of information. The incorporation of emotional stimuli within this switching framework is a key innovation, as it directly tests the interaction between affective and cognitive systems - a nexus of particular vulnerability in MDD[36,37].

Beyond dual-task designs, other innovative approaches are enriching the field. Emotional go/no-go and emotional Stroop tasks probe response inhibition under emotional interference[38]. Eye-tracking combined with ERP provides a multimodal assessment of overt and covert attention[18]. Virtual reality paradigms[39] offer enhanced ecological validity for studying attentional switching in simulated real-world environments. These methodological advances are essential for translating laboratory findings into real-world cognitive functioning (Table 3).

Table 3 Methodological paradigms for studying attentional switching in major depressive disorder: Advantages and event-related potential correlates.

Paradigm	Core cognitive demand	Key attentional process probed	Primary ERP components of interest	Strengths for MDD research
Task-switching	Shift between different task rules (e.g., classify by color vs shape)	Cognitive flexibility, set reconfiguration, rule updating	SP, P300	Isolates “pure” executive switching, minimal emotional confound
Dual-task (as in Wu et al[9])	Perform two concurrent, alternating tasks	Divided attention, rapid resource sharing, interference management	N100, P200, P300, LPP across task transitions	High ecological validity, tests ability under load resembling daily life
Emotional variant of switching	Switch attention based on emotional vs non-emotional features	Interaction between affective processing and cognitive control	N170, P200, LPP; modulation of switch-related components by emotion	Directly tests the emotion-cognition interaction deficit central to MDD
Attentional blink with emotional stimuli	Identify targets in a rapid stream; emotional distractors are inserted	Temporal attention, vulnerability to emotional disruption	P3 to targets, attenuation of P3 by emotional distractors	Probes how emotion disrupts the attentional “gate” over time
Cue-target with emotional primes	Respond to a target preceded by an emotional or neutral cue	Attentional orienting and disengagement	Cue-locked LPP, target-locked P1/N1, P300	Dissociates the stages of attention: Engagement with cue vs. disengagement to target

ERP: Event-related potential; MDD: Major depressive disorder; LPP: Late positive potential; SP: Switch-related positivity.

Comprehensive and multimodal analysis

The field is moving beyond analyzing single ERP components in isolation. As demonstrated by Wu et al[9], the simultaneous analysis of multiple components (N100, P200, P300, LPP) provides a more dynamic account of information processing. This approach enables identification of the specific stage(s) at which processing deviates from typical patterns. Additionally, there is increasing emphasis on analyzing not only amplitude and latency but also neural oscillations (e.g., theta and alpha power) and connectivity measures (e.g., phase-locking and coherence) during cognitive tasks[40]. These measures can reveal disruptions in neural synchronization and communication between brain networks (e.g., fronto-parietal control network and default mode network) that underlie cognitive control deficits in MDD[41].

The integration of ERP with other neuroimaging modalities, particularly functional magnetic resonance imaging (fMRI), represents a significant trend[42]. Simultaneous electroencephalography - functional magnetic resonance imaging-fMRI can link the millisecond temporal resolution of ERPs with the precision of fMRI, providing a more comprehensive understanding of underlying neural circuits. For instance, a reduced P300 during switching may be associated with hypoactivation in the dorsolateral prefrontal cortex, a region critical for executive control[43,44].

Statistical rigor and analytical sophistication

Wu et al[9] demonstrate notable statistical rigor through the application of mixed-design analyses of variance with appropriate corrections for multiple comparisons. The inclusion of effect-size estimates (η²p) strengthens interpretability and facilitates cross-study comparisons[45]. Furthermore, the joint analysis of both amplitude and latency provides a more comprehensive characterization of neurophysiological abnormalities than amplitude-based analysis alone. This dual-parameter approach indicates that MDD primarily affects the magnitude of neural responses rather than their timing, suggesting that cognitive dysfunction reflects insufficient resource allocation rather than generalized processing speed deficits.

CLINICAL IMPLICATIONS AND APPLICATIONS

Assessment, diagnosis, and subtyping

The objective nature of ERP biomarkers addresses a significant limitation of current clinical practice, which relies heavily on subjective self-report. Quantifiable deficits in P200 or LPP may serve as biosignatures to enhance diagnostic precision, particularly in differentiating MDD from conditions with overlapping symptoms (e.g., bipolar disorder and anxiety disorders) or in identifying subtypes of depression characterized by prominent cognitive dysfunction[46,47]. For instance, a profile showing severe LPP reduction may indicate a subtype associated with anhedonia and motivational deficits, potentially guiding treatment selection toward therapies targeting reward systems[48,49].

Treatment target and intervention guidance

ERP findings directly inform the development of novel interventions. The documented attentional bias toward negative stimuli is a direct target for attention bias modification (ABM)[50,51]. ABM protocols, often computer-based, train individuals to disengage from negative stimuli and orient toward neutral or positive stimuli. ERP measures (e.g., the P200 and LPP) can serve as objective, real-time indicators of neural plasticity during ABM, potentially enabling personalization of training intensity and duration[52]. Furthermore, neuromodulation treatments such as repetitive transcranial magnetic stimulation and transcranial direct current stimulation often target prefrontal regions implicated in cognitive control[13,53]. Baseline ERP profiles (e.g., fronto-central P300 amplitude) could predict treatment response or guide target localization[44,54].

Treatment response monitoring and prognosis

One of the most promising clinical applications is the use of ERPs as biomarkers of treatment response. Longitudinal studies tracking ERP changes (e.g., normalization of P300 or LPP amplitude) alongside symptom improvement are needed to establish their utility[14,55]. For instance, an early increase in LPP responses to positive stimuli following antidepressant initiation may predict subsequent clinical improvement, allowing for timely treatment adjustments. This approach aligns with the goals of personalized psychiatry (Table 4)[21,56,57].

Table 4 Potential clinical translation pathways for event-related potential biomarkers in major depressive disorder.

Clinical application	Description	Example ERP biomarker	Current evidence stage	Challenges
Diagnostic Aid/subtyping	Objective measure to support clinical diagnosis or define cognitively distinct subgroups	Reduced P300 amplitude; blunted LPP to rewards	Promising research evidence; requires large normative databases and defined cut-offs	High inter-individual variability; overlap with other disorders
Predictor of treatment response	Baseline ERP profile predicting likelihood of response to a specific therapy (e.g., CBT, antidepressants)	Pre-treatment RewP or frontal theta activity	Early experimental stage; several promising candidate markers	Need for large, prospective, treatment-specific studies
Monitor of treatment process	ERP changes during treatment signaling engagement of target neural mechanisms	Increase in P300/LPP to positive stimuli during ABM or antidepressant treatment	Conceptually strong; used in mechanistic research studies	Establishing causal links between neural change and clinical outcome
Target for neuromodulation	Using aberrant ERP activity (source-localized) to guide brain stimulation targets	Reduced frontal P300 mapped to DLPFC for rTMS targeting	Experimental; used in some research protocols	Requires combined EEG-source imaging and neuromodulation
Index of functional recovery	ERP normalization associated with recovery of real-world cognitive/occupational function	Correlation between P300 amplitude recovery and return-to-work measures	Longitudinal studies are beginning to explore this	Long timeframes and multifactorial nature of functional outcomes

ERP: Event-related potential; LPP: Late positive potential; RewP: Reward positivity; CBT: Cognitive behavioral therapy; Aid: Assistance in depression; DLPFC: Dorsolateral prefrontal cortex; ABM: Attention bias modification; rTMS: Repetitive transcranial magnetic stimulation; EEG: Electroencephalography.

FUNCTIONAL IMPLICATIONS

These deficits have important implications for everyday functioning. Attentional switching is fundamental to adaptive behavior in dynamic environments, and impairments in this domain likely contribute to the functional disability associated with MDD[58]. A clearer understanding of these attentional and emotional processing deficits can inform the development of compensatory strategies and environmental modifications to support functioning.

LIMITATIONS AND FUTURE DIRECTIONS

Addressing the study by Wu et al[9] and the broader literature are informative, several key limitations remain. Sample characteristics are paramount. Most studies, including Wu et al’s study[9], have modest sample sizes[59] and often include medicated participants, making it difficult to disentangle disease effects from medication effects[46]. Future research should include larger, carefully phenotyped samples, stratified by medication status, episode chronicity, and comorbidities. The cross-sectional nature of most studies limits causal inference. It remains unclear whether ERP abnormalities precede depressive symptoms, result from them, or reflect shared vulnerability factor. Longitudinal studies following high-risk cohorts (e.g., offspring of individuals with depression) and patients from the acute phase through remission are essential to determine whether these markers represent state (associated with current symptoms), trait (persistent vulnerability markers), or scar (consequences of the illness) indicators[55,60].

Future research should prioritize several key avenues to advance the field. First, longitudinal and high-risk cohort studies that track ERP measures from the premorbid stage through illness onset, treatment, and remission are essential to establish the etiological and prognostic value of these biomarkers[32,61]. Furthermore, multimodal integration - combining ERP with fMRI, magnetic resonance spectroscopy, and structural magnetic resonance imaging - will provide a multi-level understanding by linking temporal dynamics to brain circuits, neurochemistry, and anatomy[37,41,42,44]. Another critical priority is leveraging ecological momentary assessment and mobile technologies; linking laboratory-based ERP findings to real-world cognitive and emotional functioning via smartphone-based ecological momentary assessment and mobile electroencephalography - functional magnetic resonance imaging is crucial for enhancing clinical relevance. Additionally, research must clarify mechanistic specificity and conduct transdiagnostic comparisons to determine whether attentional switching deficits are specific to MDD or represent a transdiagnostic feature of internalizing disorders such as anxiety[62]. This requires direct comparisons across disorders using identical paradigms[27,28,48]. Finally, intervention studies embedding ERP measures are needed: Clinical trials of cognitive training, psychotherapy, or neuromodulation should incorporate ERP as a primary or secondary outcome to objectively demonstrate target engagement and underlying neural mechanisms (Table 5)[50-53].

Table 5 Key future research directions to advance the field.

Research direction	Core scientific question	Recommended methodological approach	Expected outcome/impact
Longitudinal trajectories	Do ERP abnormalities precede, coincide with, or follow depressive episodes? Are they normalized by treatment	Prospective studies of high-risk cohorts; treatment trials with ERP assessments at multiple timepoints	Determine causal role and clinical utility as predictive/prognostic biomarkers
Circuit mechanisms	Which specific large-scale brain networks show dysfunctional communication during attentional switching	Simultaneous EEG-fMRI; source-localized EEG connectivity analysis during switching tasks	Identify novel neurobiological targets for brain stimulation or circuit-based therapeutics
Personalized prediction	Can a combination of ERP, clinical, and genomic data predict individual treatment outcomes	Machine learning on multimodal datasets from large clinical trials	Move towards personalized medicine in psychiatry
Real-world translation	How do lab-measured ERP deficits manifest in daily life attention and functioning	Studies pairing lab-based EEG with EMA of cognition in daily life	Validate the ecological significance of ERP biomarkers and link them to patient-centered outcomes
Developmental perspective	How do attentional switching circuits and their dysfunction evolve from adolescence to late-life depression	Cross-sectional and longitudinal studies across the lifespan	Identify optimal windows for early intervention and age-specific treatment targets

ERP: Event-related potential; EEG: Electroencephalography; fMRI: Functional magnetic resonance imaging; EMA: Ecological momentary assessment.

CONCLUSION

Neuroelectrophysiological investigation of attentional switching in MDD, as exemplified by the work of Wu et al[9], has yielded significant insights. Converging evidence indicates specific, quantifiable dysfunction in millisecond-range brain dynamics underlying cognitive control, particularly in the context of emotional processing. Reductions in P200 and LPP amplitudes emerge as promising objective biomarkers, highlighting deficits in early attentional engagement and sustained elaborative processing, especially for negative information.

These findings bridge cognitive theories of depression with contemporary neuroscience, providing a mechanistic account of how negative attentional biases contribute to broader cognitive impairment and functional disability. The adoption of more ecologically valid and demanding paradigms, such as dual-task designs, represents an important step toward understanding real-world cognitive challenges in individuals with MDD.

The path forward is clear. To translate these promising neuroscientific discoveries into clinical tools that improve patient lives, the field must embrace large-scale, longitudinal, and multimodal research. Standardization of paradigms, collaboration across research centers, and a focus on individual-level prediction and mechanism-focused intervention trials are imperative. Such efforts may enable ERP and related neurophysiological measures to improve the assessment, subtyping, and treatment of cognitive dysfunction in MDD, supporting more effective and personalized mental health care.

ACKNOWLEDGEMENTS

The authors thank all researchers whose studies contributed to this article.